Literature DB >> 9890423

Mixed genotypes infection with hepatitis D virus.

J C Wu1, I A Huang, Y H Huang, J Y Chen, I J Sheen.   

Abstract

Heterogeneity of hepatitis C viral (HCV) genomes results in escape from immune clearance. Super-infection or mixed infection of different genotypes of HCV are seen commonly in humans. Hepatitis D virus (HDV) is classified into 3 genotypes. This study was planned to investigate if mixed genotypes infection of HDV occurs in humans. HDV genotyping based on restriction fragment length polymorphism (RFLP) was used to screen 60-99 HDV clones from each case of 7 prostitutes and 11 patients. Mixed infections were diagnosed by the finding of two or more different RFLP patterns in a case and were confirmed by sequencing. Five prostitutes had mixed infections of genotypes IIa and IIb HDV, while only 2 patients had mixed infections of genotypes I and II HDV (P< 0.05). The heterogeneity in nucleotide sequence was generally below 2% among HDV quasi-species from the same subject, while the heterogeneity was 27.7% between genotypes I and II HDV, and 22.8% between genotypes IIa and IIb HDV from a subject with mixed infection. Multiple HDV clones from the spouses of the 2 index cases were also analyzed. One spouse had mixed infection and the other did not, corresponding to the index cases. In cases with mixed genotypes infections, the prevalence of the minor strain was less than 10% of the total colony population analyzed.

Entities:  

Mesh:

Year:  1999        PMID: 9890423

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells.

Authors:  Tzu-Chi Wang; Mei Chao
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

4.  Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.

Authors:  Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

5.  Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.

Authors:  Abbas Ali Husseini; Khwaja Mir Islam Saeed; Esra Yurdcu; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

6.  Interaction and replication activation of genotype I and II hepatitis delta antigens.

Authors:  Sheng-Chieh Hsu; Jaw-Ching Wu; I-Jane Sheen; Wan-Jr Syu
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 7.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

8.  Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice.

Authors:  Katja Giersch; Lennart Hermanussen; Tassilo Volz; Annika Volmari; Lena Allweiss; Camille Sureau; John Casey; Jiabin Huang; Nicole Fischer; Marc Lütgehetmann; Maura Dandri
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

9.  Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombination.

Authors:  Mei Chao; Tzu-Chi Wang; Chia-Chi Lin; Robert Yung-Liang Wang; Wen-Bin Lin; Shang-En Lee; Ying-Yu Cheng; Chau-Ting Yeh; Shan-Bei Iang
Journal:  Oncotarget       Date:  2017-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.